ZURICH (Reuters) – Swiss drugmaker Novartis is set to end a late-stage clinical trial of a chronic heart failure drug early, following strong interim results. The Basel-based firm said on Monday an independent committee had unanimously recommended it close its PARADIGM-HF study…
Source:Novartis set to close heart drug study early after strong results
Monday, March 31, 2014
Novartis set to close heart drug study early after strong results
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment